Drug or technology
4 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 19, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is an active Phase 3 trial registration with no reported results; the study design and primary endpoint are specified but outcome data are not yet available.
AUG 10, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a recruiting Phase 3 trial registration with no results posted; the study design is rigorous but outcomes are not yet reported, making it a planned intervention study only.
AUG 10, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is an active Phase 3 trial registration with no results posted; the study is ongoing and has not yet reported efficacy or safety outcomes.
AUG 7, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 interventional study of neoadjuvant endocrine therapy in a specific breast cancer subtype using a surrogate endpoint (Ki67 proliferative index); recruitment completed but results not yet reported in this registry record.